CaCTUSES
Cardiac CT for intra-cardiac thrombus detection in embolic stroke of undetermined source (ESUS)
Clinical Question
Does cardiac CT angiography (CCTA) improve the detection of intra-cardiac thrombus in ESUS patients and affect secondary prevention strategy?
Bottom Line
In ESUS patients, cardiac CT detected intra-cardiac thrombus in 17% (22/129) — LV thrombus 10.1%, LAA thrombus 6.2%. Standard TTE missed 77% of these. CCTA changed management in 21% (27/129) from antiplatelet to anticoagulant. At population level, 8.2% of all ESUS patients (22/266) had thrombi detected only by CCTA. Predictors: IHD (59% vs 28%), CHF (40% vs 6%), reduced EF (mean 46% vs 57%), apical hypokinesia (59% vs 12%).
Major Points
- CCTA detected thrombus in 17% (22/129) of ESUS patients: LVT 10.1%, LAA 6.2%, LA body 0.8%.
- TTE missed 77% (17/22) of thrombi — only 5/22 even suspected on TTE.
- Changed management in 21% (27/129) — antiplatelet to anticoagulant (thrombus n=22, PE n=7).
- Population impact: 8.2% (22/266) of all ESUS patients had thrombi detectable only by CCTA.
- Predictors: IHD (59% vs 28%; P=0.01), CHF (40% vs 6%; P<0.0001), reduced EF (46% vs 57%; P<0.0001), apical hypokinesia (59% vs 12%; P<0.0001).
- All 13 LVTs in apex with wall motion abnormality. 2 had previously unknown prior MI (new dx on CCTA).
- CCTA also found PE in 7 patients and subclinical leaflet thrombosis in 2.
- Retrospective, single-center (Beilinson Hospital, Israel), 129 CCTA + 57 TEE patients.
- TEE preferred in younger (<60yr) PFO candidates; CCTA preferred in older cardiovascular-risk patients.
- Supports CCTA in routine ESUS workup, especially with apical hypokinesia, reduced EF, IHD, or CHF.
Design
Study Type: Retrospective observational study
Randomization:
Blinding:
Enrollment Period: April 2019 to October 2021
Centers: 1
Countries: Israel
Sample Size: 266
Analysis: Descriptive and comparative statistical analysis using SPSS
Inclusion Criteria
- Non-lacunar ischemic stroke
- No AF on ECG or telemetry (>20h)
- No significant arterial stenosis (>50%)
- No identifiable embolic source on transthoracic echo
Exclusion Criteria
- TIA (transient ischemic attack)
- Renal dysfunction (for contrast)
- Inability to cooperate with CT (e.g., aphasia, instability)
- Preference for TEE when evaluating valvular sources or PFO
Arms
| Field | CCTA Group |
|---|---|
| Intervention | Cardiac CT angiography performed in ESUS patients |
| Duration | Single imaging during hospitalization |
Outcomes
| Outcome | Type | Control | Intervention | HR / OR / RR | P-value |
|---|---|---|---|---|---|
| Detection of intra-cardiac thrombus on CCTA | Primary | 17% | |||
| Patients requiring anticoagulation based on CCTA | 95% CI: 14%–28% | Secondary | 21% | |||
| Overall detection of intra-cardiac thrombus in ESUS population | 95% CI: 4.9%–11.5% | Secondary | 8.2% | |||
| Observational study | Adverse | Retrospective observational study of cardiac CT in ESUS - no safety/AE data reported |
Subgroup Analysis
CCTA more commonly detected thrombi in patients with CHF or IHD. LVT was associated with apical hypokinesia on echo.
Criticisms
- Retrospective and single-center design
- No comparison between CCTA and TEE in the same patients
- No long-term outcomes reported
- Selection bias due to imaging modality availability and patient stability
Funding
None reported
Based on: CaCTUSES (European Stroke Journal, 2022)
Authors: Barnea R, Nardi Agmon I, Shafir G, ..., Hamdan A
Citation: Barnea R, et al. Eur Stroke J. 2022;7(3):212–220.
Content summarized and formatted by NeuroTrials.ai.